Pfizer Loses Norvasc Ruling: Rx Patent Extensions Are For Product, Not Use

A drug's patent term extension applies only to the FDA-approved product, not the active moiety's use, Newark federal court Judge Katharine Hayden ruled in Pfizer v. Dr. Reddy's